First Time Loading...

MedPeer Inc
TSE:6095

Watchlist Manager
MedPeer Inc Logo
MedPeer Inc
TSE:6095
Watchlist
Price: 676 JPY -1.6% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one MedPeer Inc stock under the Base Case scenario is 1 910.01 JPY. Compared to the current market price of 676 JPY, MedPeer Inc is Undervalued by 65%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
1 910.01 JPY
Undervaluation 65%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1
P/S
P/S
Price to Sales
1
vs History
98
vs Industry
68
Median 3Y
4
Median 5Y
8.3
Industry
2.4
Forward
1
More Details
23
P/E
P/E
Price to Earnings
23
vs History
98
vs Industry
25
Median 3Y
41.2
Median 5Y
64.2
Industry
23.2
Forward
25
More Details
24.4
P/OCF
P/OCF
Price to OCF
24.4
vs History
98
vs Industry
17
Median 3Y
49.9
Median 5Y
55.3
Industry
15.5
More Details
3.6
P/FCFE
P/FCFE
Price to FCFE
3.6
vs History
98
vs Industry
40
Median 3Y
46
Median 5Y
88.4
Industry
23.5
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
98
vs Industry
48
Median 3Y
4.5
Median 5Y
8.9
Industry
2.2
More Details
0.9
EV/S
EV/S
Enterprise Value to Sales
0.9
vs History
98
vs Industry
71
Median 3Y
3.2
Median 5Y
7.7
Industry
2.5
Forward
0.8
More Details
1.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.8
vs History
98
vs Industry
72
Median 3Y
5.5
Median 5Y
11.6
Industry
5.2
More Details
6.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6.9
vs History
98
vs Industry
42
Median 3Y
22.4
Median 5Y
35.2
Industry
12.5
Forward
8
More Details
12.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.4
vs History
96
vs Industry
35
Median 3Y
25.3
Median 5Y
40
Industry
17.2
More Details
21.3
EV/OCF
EV/OCF
Enterprise Value to OCF
21.3
vs History
98
vs Industry
21
Median 3Y
45.3
Median 5Y
50.2
Industry
15.1
More Details
25.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
25.9
vs History
98
vs Industry
20
Median 3Y
58.3
Median 5Y
66.2
Industry
19.7
More Details
1.3
EV/IC
EV/IC
Enterprise Value to IC
1.3
vs History
98
vs Industry
53
Median 3Y
9.5
Median 5Y
22.2
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
MedPeer Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
MedPeer Inc
TSE:6095
14.7B JPY 1 23 6.9 12.4
US
Veeva Systems Inc
NYSE:VEEV
32.5B USD 13.7 61.8 61.6 66.3
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.7B AUD 80.1 168 115.5 115.5
US
Inspire Medical Systems Inc
NYSE:INSP
7.4B USD 11.9 -351 -186.1 -173
JP
M3 Inc
TSE:2413
1.1T JPY 4.8 24.1 12.5 14.1
US
Doximity Inc
NYSE:DOCS
4.5B USD 9.7 32.9 22 23.5
SE
Sectra AB
STO:SECT B
42B SEK 25.6 98.9 -65.1 -65.1
US
Evolent Health Inc
NYSE:EVH
3.1B USD 1.6 -21.9 25.9 275.5
US
Certara Inc
NASDAQ:CERT
2.8B USD 7.9 -50.9 46.1 461.9
P/E Multiple
Earnings Growth
JP
MedPeer Inc
TSE:6095
Average P/E: 65.1
23
45%
US
Veeva Systems Inc
NYSE:VEEV
61.8
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
168
119%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -351 N/A
JP
M3 Inc
TSE:2413
24.1
26%
US
Doximity Inc
NYSE:DOCS
32.9
79%
SE
Sectra AB
STO:SECT B
98.9
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -21.9 N/A
US
Certara Inc
NASDAQ:CERT
Negative Multiple: -50.9 N/A
EV/EBITDA Multiple
EBITDA Growth
JP
MedPeer Inc
TSE:6095
Average EV/EBITDA: 36.3
6.9
9%
US
Veeva Systems Inc
NYSE:VEEV
61.6
221%
US
Cerner Corp
NASDAQ:CERN
19.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
16.5
N/A
AU
Pro Medicus Ltd
ASX:PME
115.5
124%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -186.1 N/A
JP
M3 Inc
TSE:2413
12.5
24%
US
Doximity Inc
NYSE:DOCS
22
103%
SE
Sectra AB
STO:SECT B
Negative Multiple: -65.1 N/A
US
Evolent Health Inc
NYSE:EVH
25.9
194%
US
Certara Inc
NASDAQ:CERT
46.1
143%
EV/EBIT Multiple
EBIT Growth
JP
MedPeer Inc
TSE:6095
Average EV/EBIT: 124.4
12.4
N/A
US
Veeva Systems Inc
NYSE:VEEV
66.3
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
AU
Pro Medicus Ltd
ASX:PME
115.5
110%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -173 N/A
JP
M3 Inc
TSE:2413
14.1
N/A
US
Doximity Inc
NYSE:DOCS
23.5
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -65.1 N/A
US
Evolent Health Inc
NYSE:EVH
275.5
2 086%
US
Certara Inc
NASDAQ:CERT
461.9
2 181%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.